← Open Payments lookup

JAIRO GOMEZ: Open Payments

NPI 1417055104 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,151 in 77 payments from 10 companies in 2025. Trend: 2023 $2,762 · 2024 $3,018 · 2025 $3,151

Food & beverage: $3,151
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc13$775
Otsuka America Pharmaceutical, Inc.23$693
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$402
E.R. Squibb & Sons, L.L.C.14$381
Alkermes, Inc.3$266
ABBVIE INC.3$159
Neurocrine BioSciences, Inc.2$157
Teva Pharmaceuticals USA, Inc.5$131
Janssen Biotech, Inc.1$123
Vanda Pharmaceuticals Inc.3$65

Products named: INVEGA SUSTENNA, CAPLYTA, COBENFY, ABILIFY ASIMTUFII, REXULTI, VRAYLAR, INGREZZA, ABILIFY MAINTENA.

Industry payments across CA — which companies pay providers there.